CIITA and acute myeloid leukemia: CIITA is a vital regulator of MHC class II gene expression including HLA-DR, HLA-DP and HLA-DQ, deregulation of which promoted abolishment of recognition from donor T cell, and lead to AML relapse after allo-HCT [28].